This page is part of the NHSN Reporting of Adverse Drug Events - Hypoglycemia (v1.0.0: STU 1 on FHIR R4) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions
<MedicationAdministration xmlns="http://hl7.org/fhir">
<id value="medicationadministration-metformin-er"/>
<meta>
<versionId value="4"/>
<lastUpdated value="2021-03-30T01:37:24.451+00:00"/>
<source value="#t2FnpwH0BmpwZidT"/>
<profile
value="http://hl7.org/fhir/us/nhsn-ade/StructureDefinition/MedicationAdministration-Antidiabetics"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative</b></p><p><b>status</b>: completed</p><p><b>medication</b>: <span title="Codes: {http://www.nlm.nih.gov/research/umls/rxnorm 1043563}">24 HR metformin hydrochloride 1000 MG / saxagliptin 2.5 MG Extended Release Oral Tablet</span></p><p><b>subject</b>: <a href="Patient-patient-ade-1.html">Generated Summary: id: ?ngen-9?; active; ; gender: female; birthDate: 1974-11-24</a></p><p><b>context</b>: <a href="Encounter-encounter-completed-inpatient-ade-1.html">Generated Summary: status: finished; <span title="{http://terminology.hl7.org/CodeSystem/v3-ActCode IMP}">inpatient encounter</span>; <span title="Codes: {http://snomed.info/sct 24882007}">Medical consultation on hospital inpatient</span>; period: 2020-08-01 --> 2020-08-12</a></p><p><b>effective</b>: Jan 4, 2021 3:30:00 AM</p><h3>Dosages</h3><table class="grid"><tr><td>-</td><td><b>Route</b></td><td><b>Method</b></td><td><b>Dose</b></td></tr><tr><td>*</td><td><span title="Codes: {http://snomed.info/sct 26643006}">Oral Route</span></td><td><span title="Codes: {http://snomed.info/sct 421521009}">Swallow - dosing instruction imperative (qualifier value)</span></td><td>2 TAB</td></tr></table></div>
</text>
<status value="completed"/>
<medicationCodeableConcept>
<coding>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<code value="1043563"/>
<display
value="24 HR metformin hydrochloride 1000 MG / saxagliptin 2.5 MG Extended Release Oral Tablet"/>
</coding>
<text
value="24 HR metformin hydrochloride 1000 MG / saxagliptin 2.5 MG Extended Release Oral Tablet"/>
</medicationCodeableConcept>
<subject>
<reference value="Patient/patient-ade-1"/>
</subject>
<context>
<reference value="Encounter/encounter-completed-inpatient-ade-1"/>
</context>
<effectiveDateTime value="2021-01-04T04:30:00+01:00"/>
<dosage>
<route>
<coding>
<system value="http://snomed.info/sct"/>
<code value="26643006"/>
<display value="Oral Route"/>
</coding>
</route>
<method>
<coding>
<system value="http://snomed.info/sct"/>
<code value="421521009"/>
<display
value="Swallow - dosing instruction imperative (qualifier value)"/>
</coding>
</method>
<dose>
<value value="2"/>
<unit value="TAB"/>
<system value="http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm"/>
<code value="TAB"/>
</dose>
</dosage>
</MedicationAdministration>